Intellectual Property India Publishes Patent Application for 'Fibroblast Activation Protein (FAP) Inhibitors, FAP Conjugates, And Diagnostic And Therapeutic Uses Thereof' Filed by Nuclidium Ag; and University Of Basel

MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202517037485 A) filed by Nuclidium Ag; and University Of Basel, Basel, Switzerland, on April 17, for 'fibroblast activation protein (fap) inhibitors, fap conjugates, and diagnostic and therapeutic uses thereof.'

Inventor(s) include Jaafar-Thiel, Leila; Fani, Melpomeni; Millul, Jacopo; and De Rose, Francesco.

The application for the patent was published on May 9, under issue no. 19/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to the field of fibroblast activation protein (FAP) inhibitors, conjugates comprising the novel FAP inhibitors, including radiotracers, for the imaging, diagnosis and...